Parkinson's Phase 3 Study Creatine Report for Patients Like You

Filter by:

All
Start typing to see suggestions

patients

Home > Community Treatment Reports and Side Effects > Parkinson's Phase 3 Study Creatine Treatment Report

You appear to have JavaScript disabled in your browser. PatientsLikeMe relies on JavaScript and Cookies to deliver the best possible experience to you. How do I enable JavaScript?

What is Parkinson's Phase 3 Study Creatine?

NCT00449865 is a multicenter, double-blind, parallel group, placebo controlled study of creatine in subjects with treated Parkinson's Disease (PD) Long Term Study (LS-1). Other study IDs include: U01NS43128 NET-PD, CRC, NET-PD LS-1.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose	# of patients	# of patients with evaluations Efficacy	Major	Moderate	Slight	None	Can’t tell
Participate in clinical trial	2	0
maintain muscle tone and movement	1	0

See all 2 patients currently using Parkinson's Phase 3 Study Creatine

Mouse over the table for more information

Reported Schedules

	1 mg daily	5 g daily
	1	1

Reported Duration See details about how long patients take this treatment ▼ Reported Duration Hide details ▲

Currently Using Parkinson's Phase 3 Study Creatine

A bar graph

0-1 month	1-3 months	3-6 months	6 months-1year	1-2 years	2 years or more
0	0	0	0	0	1

Report created on May 27, 2012.